The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
about
Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levelsDevelopment of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulusResistance and susceptibility to filarial infection with Litomosoides sigmodontis are associated with early differences in parasite development and in localized immune reactionsHuman onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response.Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigensDifferential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity.Lymphatic filariasis: parallels between the immunology of infection in humans and mice.Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India.In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.Can intestinal helminth infections (geohelminths) affect the development and expression of asthma and allergic disease?Cellular cytokine and chemokine responses to parasite antigens and fungus and mite allergens in children co-infected with helminthes and protozoa parasitesModeling targeted ivermectin treatment for controlling river blindness.Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergyRegulatory T cell subsets in filarial infection and their function.Future prospects and challenges of vaccines against filariasis.Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift.Down-regulated lymphoproliferation coincides with parasite maturation and with the collapse of both gamma interferon and interleukin-4 responses in a bovine model of onchocerciasisOnchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.Applied field research for comprehensive helminth infection control.Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.Topical application of diethylcarbamazine to detect onchocerciasis recrudescence in west Africa.Antibody responses in onchocerciasis as a function of age and infection intensity.Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo.
P2860
Q28539936-6E25402D-98F6-4EC1-B990-33126CC0AA0AQ30635427-74CB3175-9012-4D15-8CAB-042D23CE8827Q31028656-2139BA14-46DE-40AF-A40F-5560E994F617Q34002502-B50309F0-B691-49E5-A602-E18EA8BCF33DQ34003825-B3B28D68-9270-4E24-BB79-4ED666D63976Q34122804-212DD709-1471-40B0-BD1C-27C9EA202536Q34319419-54916AF3-8C46-4EE1-877D-CBCF130D7827Q34319430-F583C9DA-06E5-4B65-9E89-90E0BCA39D4BQ34596221-687F617D-8AA1-4383-8715-59B60DC3E435Q34687582-E721E96C-0C32-4AA3-889F-E8F0A1A0DAE9Q35101914-F3D7FD59-6BB3-4965-A933-DD94E2858608Q35647918-F5C861BB-D59F-4174-81D2-3B3B0FDD8837Q35920663-DCEA9644-6FFA-41CA-99A1-30418F0868E1Q37205678-23F66E98-004E-4F09-A790-B8906269FB9DQ37965765-2A37186C-3112-46BE-AF20-D80729F0F75FQ38975096-91469C71-072C-4249-8257-ECACDA7103A7Q39030931-FD944A7A-7054-4F74-877F-9E44E2A18D64Q39205393-EB13CE1B-FA1D-4513-8406-8575057B2090Q39352954-AAC50CE2-3439-4D0A-8DED-17C3A4FB66CDQ39475268-2834FCE2-2477-4F9F-96B3-EEEDF34ADA48Q39475282-9A10426B-8363-4926-B2FA-1A4DFD29AB3CQ39475291-081628A3-B93D-49BA-B2B7-17C2DC74D4A3Q43934766-B465D582-8D58-441C-832D-B850C543A6C9Q44571474-33AE0404-011F-41D8-ACE3-A4FB6AAAF78EQ47339691-CA83EE71-EDE5-40F0-8075-568B7214C4BDQ55133116-062E3636-4E0B-4887-98CB-8939A0750136
P2860
The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The diverse expression of immu ...... Onchocerca volvulus infection.
@en
The diverse expression of immu ...... Onchocerca volvulus infection.
@nl
type
label
The diverse expression of immu ...... Onchocerca volvulus infection.
@en
The diverse expression of immu ...... Onchocerca volvulus infection.
@nl
prefLabel
The diverse expression of immu ...... Onchocerca volvulus infection.
@en
The diverse expression of immu ...... Onchocerca volvulus infection.
@nl
P2093
P1433
P1476
The diverse expression of immu ...... Onchocerca volvulus infection.
@en
P2093
Batchassi E
Dreweck CM
Schulz-Key H
Soboslay PT
P304
P356
10.1046/J.1365-2567.1997.00210.X
P577
1997-04-01T00:00:00Z